| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/16/2009 | US20090098153 Activation of HCV-specific T cells |
| 04/16/2009 | US20090098144 Immunogen presenting hiv gp120 v3 loop in a conformation that induces broadly neutralizing antibodies |
| 04/16/2009 | US20090098085 Tetrazolyl acyclic hepatitis c serine protease inhibitors |
| 04/16/2009 | US20090098081 System for providing a method for applying a skin sealant having a phase change visual indicating component |
| 04/16/2009 | CA2704009A1 Preparation, use of preparation for treatment, and method of treatment of intestinal infection |
| 04/16/2009 | CA2702257A1 Broad spectrum beta-lactamase inhibitors |
| 04/16/2009 | CA2702132A1 Spiropyrrolidines and their use against hcv and hiv infection |
| 04/16/2009 | CA2701764A1 Photodynamic therapy process and photosensitizer compositions |
| 04/16/2009 | CA2701727A1 Cytomegalovirus vaccines and methods of production |
| 04/16/2009 | CA2700937A1 Method of eliciting an immune response against pandemic influenza virus |
| 04/16/2009 | CA2699169A1 Therapeutic uses of intermedin 47 and 53 peptides |
| 04/16/2009 | CA2699168A1 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent |
| 04/16/2009 | CA2699163A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | CA2699088A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | CA2699084A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent |
| 04/16/2009 | CA2699083A1 Use of a peptide as a therapeutic agent |
| 04/15/2009 | EP2048505A2 Method for early recognition of the seroconversion of an antibody to hepatitis C |
| 04/15/2009 | EP2048163A1 Antihuman alpha- 9 integrin antibody and use of the same |
| 04/15/2009 | EP2048158A1 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 04/15/2009 | EP2048150A1 Benzyl phenyl glucopyranoside derivative |
| 04/15/2009 | EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 04/15/2009 | EP2048141A1 Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases |
| 04/15/2009 | EP2047860A1 Phamaceutical compositons comprosing actinomycete glycerol acyl derivatives antigens, their process of extractin, and their use against tuberculosis. |
| 04/15/2009 | EP2047857A1 Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 04/15/2009 | EP2047856A1 Agent for preventing infection |
| 04/15/2009 | EP2047855A1 Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants) |
| 04/15/2009 | EP2047850A2 Methods for treating diseases through inhibition of the function of molecular chaperones such as protein disulfide isomerases , pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
| 04/15/2009 | EP2046802A2 Novel 2-substituted methyl penam derivatives |
| 04/15/2009 | EP2046775A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 04/15/2009 | EP2046774A1 Pyrazole derivatives as cytochrome p450 inhibitors |
| 04/15/2009 | EP2046767A2 Process for preparing diaminophenothiazinium compounds |
| 04/15/2009 | EP2046740A1 Compounds having crth2 antagonist activity |
| 04/15/2009 | EP2046731A1 Non-nucleoside reverse transcriptase inhibitors |
| 04/15/2009 | EP2046452A2 Antibiotic composition |
| 04/15/2009 | EP2046379A2 Immunogenic proteins of burkholderia pseudomallei and uses thereof |
| 04/15/2009 | EP2046378A2 Use of bacterial polysaccharides for biofilm inhibition |
| 04/15/2009 | EP2046349A1 Treatment of excessive neovascularization |
| 04/15/2009 | EP2046328A2 Pyridinone diketo acids: inhibitors of hiv replication in combination therapy |
| 04/15/2009 | EP2046316A1 Antiviral use of cationic surfactant |
| 04/15/2009 | EP2003130A9 Novel pyridine derivative having anti-helicobacter pylori activity |
| 04/15/2009 | EP1719773B1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor |
| 04/15/2009 | EP1562628B1 Dc-sign blockers and their use for preventing or treating viral infections. |
| 04/15/2009 | EP1551763B1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 04/15/2009 | EP1543016B1 New 3-decladinosyl derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a 9a,11-cyclic carbamates |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/15/2009 | EP1257295B1 Factor vii or viia-like molecules |
| 04/15/2009 | EP1244648B1 Chemokine receptor binding heterocyclic compounds |
| 04/15/2009 | EP1212446B1 Viral replicons and viruses dependent on inducing agents |
| 04/15/2009 | EP1012267B1 An antisense oligonucleotide preparation method |
| 04/15/2009 | CN101410519A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 04/15/2009 | CN101410518A dsRNA compositions and methods for treating HPV infection |
| 04/15/2009 | CN101410414A Synergistic compositions for treating HIV-1 |
| 04/15/2009 | CN101410407A Substituted adenines and the uses thereof |
| 04/15/2009 | CN101410394A HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines |
| 04/15/2009 | CN101410372A Novel lactams |
| 04/15/2009 | CN101410368A Viral polymerase inhibitors |
| 04/15/2009 | CN101410138A New immunoglobulin concentrate useful as medicament for chikungunya virus |
| 04/15/2009 | CN101410136A Concentrate of immunoglobulins and F(ab)'2 and/or Fab fragments specific of an arbovirus as medicine |
| 04/15/2009 | CN101410135A Immunogenic composition |
| 04/15/2009 | CN101410122A Method and composition for treating anaphylactic disease |
| 04/15/2009 | CN101410109A Antibiotic compositions of modified release and process of production thereof |
| 04/15/2009 | CN101410090A Biguanide-containing liposomes |
| 04/15/2009 | CN101407809A Specific inference hog cholera virus genome sequence and method for efficiently curing hog cholera virus infection |
| 04/15/2009 | CN101407534A 2'-fluoro-4'-substituted-nucleoside analogue and use thereof |
| 04/15/2009 | CN101407525A Cephalosporin derivatives |
| 04/15/2009 | CN101407520A Novel medical uses of aporphine alkaloid and derivative thereof |
| 04/15/2009 | CN101407513A Method for synthesizing nucleoside analogue |
| 04/15/2009 | CN101407505A Antivirus andrographolide derivative and preparation thereof |
| 04/15/2009 | CN101407502A N-(t-butoxy carbonyl ) timonacic compounds, and preparation and use thereof |
| 04/15/2009 | CN101407476A M-bis(arene) polysubstituted amino benzene compound as non-nucleoside HIV reverse transcriptase inhibitor, and preparation and use thereof |
| 04/15/2009 | CN101406701A Adjuvant capable of improving dendritic cell vaccine efficiency |
| 04/15/2009 | CN101406699A Method for preparing lyophilized hepatitis A attenuated live vaccine using cell factory |
| 04/15/2009 | CN101406698A Dog type II adenovirus live vector recombinant vaccine for displaying protective antigen of rabies virus |
| 04/15/2009 | CN101406697A Bacillus pyocyaneus vaccine and preparation method thereof |
| 04/15/2009 | CN101406683A Chinese medicine compound and preparation method thereof |
| 04/15/2009 | CN101406678A Medicament for preventing and treating influenza of domestic bird |
| 04/15/2009 | CN101406675A Medicine for treating hepatitis B |
| 04/15/2009 | CN101406673A Oral liquid special for treating vital myocarditis of children |
| 04/15/2009 | CN101406661A Compound medicament for treating bacterial enteritis of aquatic livestock |
| 04/15/2009 | CN101406653A Chinese medicinal pill for treating senile pulmonary tuberculosis |
| 04/15/2009 | CN101406652A Chinese medicine capsule for treating tinea corporis |
| 04/15/2009 | CN101406638A Medicament for treating newcastle disease |
| 04/15/2009 | CN101406637A Medicament for treating infectious bursal disease of chicken |
| 04/15/2009 | CN101406634A Medicament for treating epidemic parotitis |
| 04/15/2009 | CN101406626A Oral medicament for treating pulmonary tuberculosis |
| 04/15/2009 | CN101406620A Chinese medicine oral liquid for resisting AIDS and detoxication |
| 04/15/2009 | CN101406617A Technique for preparing oral liquid for alleviating fever and detoxifcation |
| 04/15/2009 | CN101406613A Use of Chinese medicinal composition in preparing medicament for treating vital myocarditis |
| 04/15/2009 | CN101406607A Antibiotic and antiphlogistic medicine for preventing and treating bacteriosis of aquatic livestock |
| 04/15/2009 | CN101406588A Externally appiled chinese medicine for treating bone tuberculosis |
| 04/15/2009 | CN101406533A Chinese medicine for treating and preventing hyperpyrexia and pestilence of livestock |
| 04/15/2009 | CN101406529A Medicament for treating herpes zoster |
| 04/15/2009 | CN101406526A Compound scutellaria microemulsion formulation and preparation method thereof |
| 04/15/2009 | CN101406522A Use of pharmaceutical composition in preparing medicament for treating viral influenza |
| 04/15/2009 | CN101406521A Use of Magnolia grandiflora leaf volatile oil in pharmacy |
| 04/15/2009 | CN101406514A External use medicament for treating dermatophytosis |
| 04/15/2009 | CN101406492A Compound Cordyceps sinensis oil soft capsule and preparation technique |
| 04/15/2009 | CN101406471A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases |
| 04/15/2009 | CN101406466A Cinnamic acid transdermal patch and preparation technique thereof |